Study of Relacorilant in Combination with NabPaclitaxel in Patients with Metastatic Pancreatic Ductal Adenocarcinoma (CORT125134-553)
Study of Relacorilant in Combination with NabPaclitaxel in Patients with Metastatic Pancreatic Ductal Adenocarcinoma (CORT125134-553)
Trial Category:
Gastrointestinal
Phase
II
Contact(s)
Location(s)
Nebraska Cancer Specialists, Omaha, NE